Home/Filings/4/0000899243-22-025017
4//SEC Filing

BEVERIDGE, ROY A 4

Accession 0000899243-22-025017

CIK 0001571498other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 5:06 PM ET

Size

5.1 KB

Accession

0000899243-22-025017

Insider Transaction Report

Form 4
Period: 2022-06-30
Transactions
  • Award

    Common Stock, par value $0.0001

    2022-06-30$1.47/sh+8,928$13,12446,037 total
Footnotes (1)
  • [F1]The shares were issued to the Reporting Person pursuant to his election under the Issuer's director compensation program to receive such shares in lieu of cash fees of $13,125 for Board services for the second fiscal quarter of 2022. The shares were issued on the last day of the second fiscal quarter and the number of shares was calculated by dividing the cash fees to be paid for the quarter by the closing price of the Issuer's common stock on the last trading day of the quarter.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001579300

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:06 PM ET
Size
5.1 KB